These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15921313)

  • 1. [Experimental study on polylactic glycolate acid microparticles with releasing-slowly vascular endothelial growth factor].
    Chen Y; Luo X; Xiao J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Apr; 19(4):262-3. PubMed ID: 15921313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model.
    Formiga FR; Pelacho B; Garbayo E; Abizanda G; Gavira JJ; Simon-Yarza T; Mazo M; Tamayo E; Jauquicoa C; Ortiz-de-Solorzano C; Prósper F; Blanco-Prieto MJ
    J Control Release; 2010 Oct; 147(1):30-7. PubMed ID: 20643169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings.
    Norton LW; Tegnell E; Toporek SS; Reichert WM
    Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of protein delivery from modular polymer scaffolds.
    Lee M; Chen TT; Iruela-Arispe ML; Wu BM; Dunn JC
    Biomaterials; 2007 Apr; 28(10):1862-70. PubMed ID: 17184836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model.
    Kim TK; Burgess DJ
    J Pharm Pharmacol; 2002 Jul; 54(7):897-905. PubMed ID: 12162707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
    Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
    Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
    da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
    Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
    Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
    Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.
    Hedberg EL; Shih CK; Solchaga LA; Caplan AI; Mikos AG
    J Control Release; 2004 Nov; 100(2):257-66. PubMed ID: 15544873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice.
    Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H
    J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
    Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
    J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of proteins in biodegradable polymeric microparticles using electrospray in the Taylor cone-jet mode.
    Xie J; Wang CH
    Biotechnol Bioeng; 2007 Aug; 97(5):1278-90. PubMed ID: 17216662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.